OptimizeRx (OPRX) Total Current Liabilities (2010 - 2026)

OptimizeRx has disclosed Total Current Liabilities across 17 years of filings, most recently posting $9.7 million for Q2 2026.

• In Q2 2026, Total Current Liabilities fell 53.88% year-over-year to $9.7 million; the TTM figure through Jun 2026 stood at $9.7 million (down 53.88% YoY), while the FY2025 annual figure was $21.3 million, up 13.99% from the prior year.
• Total Current Liabilities came in at $9.7 million for Q2 2026 at OptimizeRx, down from $10.5 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $21.3 million in Q4 2025 to a low of $5.5 million in Q2 2023.
• Average Total Current Liabilities over 5 years is $12.8 million, with a median of $12.5 million recorded in 2024.
• Year-over-year, Total Current Liabilities jumped 171.45% in 2024 and slumped 53.88% in 2026.
• Over 5 years, Total Current Liabilities stood at $8.4 million in 2022, then jumped by 112.99% to $17.9 million in 2023, then advanced by 4.32% to $18.7 million in 2024, then rose by 13.99% to $21.3 million in 2025, then sank by 54.33% to $9.7 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $9.7 million in Q2 2026, $10.5 million in Q1 2026, and $21.3 million in Q4 2025.